glp-1 weight loss effects Adverse of class drugs. Gastrointestinal issues are Weight Loss and Maintenance Related

Overexpression of Plakophilin2 mitigates capillary leak syndrome in severe acute pancreatitis by activating the p38/MAPK signaling pathway

Dose Adjustments: Renal Insufficiency: Patients with severe kidney disease require very close monitoring

Prescription agents (e.g., semaglutide) : Stronger clinical evidence, FDA-regulated, but may carry more systemic side effects

Consumers are increasingly seeking products that are derived from natural sources, which may enhance their appeal and perceived safety

Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting -msh analog in healthy overweight and obese subjects